The American Society of Clinical Psychopharmacology Presents Dr. Kadiamada N.R. Chengappa with Best Paper in Journal Award

Congratulations to Kadiamada N.R. Chengappa, MD on his selection by the American Society of Clinical Psychopharmacology for its Best Paper in Journal Award.  

The award was presented to Dr. Chengappa on June 23rd at the Society's annual meeting in Miami Beach, FL in recognition of his article titled "Smoking Cessation in Bipolar Disorder: A Double-Blind, Placebo-Controlled Study."

Dr. Chengappa is Professor of Psychiatry at the University of Pittsburgh School of Medicine and Chief of Comprehensive Recovery Services at Western Psychiatric Institute and Clinic of UPMC.  His research has included clinical trials of antipsychotic, anticonvulsant and smoking cessation agents in persons with schizophrenia, schizoaffective or bipolar disorder.  In recent years, Dr. Chengappa has studied the use of natural substances for bipolar depression and as potential cognition enhancing agents in people with schizophrenia or bipolar disorder.